Some recent studies have shown that SLC35C1 is found to be a negative driver of the classical Wnt pathway in colon cancer species and that deletion of SLC35C1 promotes colon cancer progression by activating the Wnt signaling pathway5. Here, SLC35C1 is linked to colonic neoplasm.